Gowoonsesang Cosmetics, previously owned by Swiss retailer Migros, was acquired by L’Oréal Group in March. This marked the company’s second K-Beauty acquisition, following its earlier purchase of the 3CE brand.
Dr.G: The star performer in Gowoonsesang’s portfolio
According to South Korean media reports, Gowoonsesang Cosmetics has informed clients that it will cease operations of its other brands, Vividraw and Heals. Support for stock management and sales promotion will continue until the end of the year.
The parent company recorded sales of ₩226 billion last year, but 90% of the total revenue was generated by the Dr.G brand.
Dr.G is a doctor-backed, ingredient-led derma skincare brand, best known in Korea for its best-selling R.E.D Blemish range and its line of sun care products. It was founded by dermatologist Dr Gun Young Ahn in 2003 and is headquartered in Seoul
For over a decade, Dr.G has been one of South Korea’s leading skincare brands, with a growing presence across Asia and internationally.
When L’Oréal Group announced the acquisition, it noted that Dr.G “consistently ranks among the top three mass market and dermo-cosmetic skincare brands in the country.”
Global expansion plans for Dr.G
The L’Oréal Group also stated that the brand is well-positioned to meet rising global demand for K-Beauty and scientifically developed, effective yet affordable skincare solutions.
Alexis Perakis-Valat, Global President of L’Oréal’s Consumer Products Division, said the acquisition “perfectly complements” the division’s existing skincare portfolio.
“We have been following the brand and its success for many years, and we look forward to accelerating its growth in South Korea and the rest of the world,” she said.
The move also fits with the growing trend among Korean beauty firms to consolidate their portfolios and prioritise high-margin, globally scalable brands.
